Getz Brothers
2
7M
1
0.08
0.50
- Areas of investment
Summary
In 1997 was created Getz Brothers, which is appeared as Corporate Investor.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Getz Brothers, startups are often financed by Peppermint Venture Partners, NRW.BANK, High-Tech Gru00fcnderfonds. The meaningful sponsors for the fund in investment in the same round are Peppermint Venture Partners, Creathor Ventures, NRW.BANK. In the next rounds fund is usually obtained by Peppermint Venture Partners, Creathor Ventures, Meusinvest.
Among the various public portfolio startups of the fund, we may underline CryoTherapeutics, CryoTherapeutics The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Medical, Therapeutics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The important activity for fund was in 2016. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 5 - 10 millions dollars.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Rounds per year
- 0.08
- Follow on index
- 0.50
- Investments by industry
- Therapeutics (2)
- Biotechnology (2)
- Health Care (2)
- Therapeutic Devices (2)
- Medical (2) Show 1 more
- Investments by region
-
- Germany (2)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CryoTherapeutics | 27 Jun 2019 | Therapeutic Devices, Biotechnology, Health Care, Medical, Therapeutics, Clinical Trials | Early Stage Venture | 8M | Brandenburg, Potsdam, Germany |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.